- Home
- XXII vs RSLS Comparison
XXII vs RSLS Comparison
Compare XXII & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- RSLS
- Stock Information
- Founded
- XXII 1998
- RSLS 2002
- Country
- XXII United States
- RSLS United States
- Employees
- XXII N/A
- RSLS N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- RSLS Medical/Dental Instruments
- Sector
- XXII Health Care
- RSLS Health Care
- Exchange
- XXII Nasdaq
- RSLS Nasdaq
- Market Cap
- XXII 2.8M
- RSLS 3.2M
- IPO Year
- XXII N/A
- RSLS 2007
- Fundamental
- Price
- XXII $3.95
- RSLS $3.57
- Analyst Decision
- XXII
- RSLS Hold
- Analyst Count
- XXII 0
- RSLS 1
- Target Price
- XXII N/A
- RSLS N/A
- AVG Volume (30 Days)
- XXII 2.6M
- RSLS 43.6K
- Earning Date
- XXII 03-27-2025
- RSLS 03-31-2025
- Dividend Yield
- XXII N/A
- RSLS N/A
- EPS Growth
- XXII N/A
- RSLS N/A
- EPS
- XXII N/A
- RSLS N/A
- Revenue
- XXII $17,304,000.00
- RSLS $8,183,000.00
- Revenue This Year
- XXII $56.94
- RSLS $17.47
- Revenue Next Year
- XXII $2.98
- RSLS $20.00
- P/E Ratio
- XXII N/A
- RSLS N/A
- Revenue Growth
- XXII N/A
- RSLS N/A
- 52 Week Low
- XXII $3.80
- RSLS $3.23
- 52 Week High
- XXII $581.85
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- XXII 37.42
- RSLS 33.36
- Support Level
- XXII $4.80
- RSLS $3.23
- Resistance Level
- XXII $12.49
- RSLS $3.92
- Average True Range (ATR)
- XXII 1.08
- RSLS 0.31
- MACD
- XXII 0.02
- RSLS -0.08
- Stochastic Oscillator
- XXII 3.50
- RSLS 19.21
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.